Important role of CYP2J2 in protein kinase inhibitor degradation: a possible role in intratumor drug disposition and resistance.
We have investigated in vitro the metabolic capability of 3 extrahepatic cytochromes P-450, CYP1A1, 1B1 and 2J2, known to be over-expressed in various tumors, to biotransform 5 tyrosine kinase inhibitors (TKI): dasatinib, imatinib, nilotinib, sorafenib and sunitinib. Moreover, mRNA expression of CYP...
Main Authors: | Céline Narjoz, Amélie Favre, Justin McMullen, Philippe Kiehl, Michael Montemurro, William D Figg, Philippe Beaune, Isabelle de Waziers, Bertrand Rochat |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4018390?pdf=render |
Similar Items
-
Immunogenic cell death in a combined synergic gene- and immune-therapy against cancer
by: Benjamin Nayagom, et al.
Published: (2019-12-01) -
The role of dispositions in explanations
by: Agustín VICENTE
Published: (2010-01-01) -
Citalopram in vitro metabolism in a beagle dog: A role for CYP2D15 in the production of toxic didesmethylcitalopram?
by: B Rochat, et al.
Published: (2023-04-01) -
Combined and independent effects of OCT1 and CYP2D6 on the cellular disposition of drugs
by: Lukas Gebauer, et al.
Published: (2023-05-01) -
CYP2B6*6 genotype specific differences in artemether‐lumefantrine disposition in healthy volunteers
by: Abdullahi, ST, et al.
Published: (2019)